Oregon Health And Science University

The steroidogenesis inhibitor levoketoconazole improved and normalized morning urinary free cortisol concentrations for adults with endogenous Cushing’s disease compared with placebo, according to an industry press release.

The pandemic has accelerated digitalization in all fields, including health care.

The COVID-19 pandemic presents substantial challenges for pituitary disease management, and clinicians should consider local conditions and hospital resources when opting for surgery vs. medical management, according to new guidance.

As clinicians around the country rapidly transition from in-person to telehealth visits during the COVID-19 pandemic, many changes must be managed at once. Endocrinologists in particular are working to find new ways to support people with diabetes who rely on data-driven care and multiple in-person visits each year, as well as patients with other chronic endocrine conditions that require close follow-up, such as osteoporosis, pituitary tumors or adrenal disease.

Most oncology clinical trials that assess quality of life do so only during or shortly after the treatment or intervention rather than continuing after disease progression or until death, according to results of a cross-sectional analysis published in JAMA Network Open.

Medical cannabis is now legal in 33 states, most of which consider cancer a qualifying condition for its use in symptom palliation.

With one in six cancer survivors reporting high-impact chronic pain that limits their life and work activities, palliative care increasingly has been recognized as an important component of cancer treatment and survivorship.

Many academic oncologists at U.S. public medical schools receive considerable industry payments, some of which are sizeable compared with their annual salaries, according to a research letter published in JAMA Internal Medicine.

Nontuberculous mycobacterial (NTM) lung disease is a chronic and debilitating condition, and although considered rare, some studies have estimated that prevalence is increasing about 8% each year in the United States. In 2019, it was estimated that 98,000 to 113,000 patients were diagnosed with the condition, according to unpublished data.

ORLANDO — Targeted conditioning with anti-CD45 iodine apamistamab enabled older, heavily pretreated patients with relapsed or refractory acute myeloid leukemia to undergo hematopoietic stem cell transplantation with successful engraftment, according to preliminary results of the randomized phase 3 SIERRA trial presented at TCT | Transplantation & Cellular Therapy Meetings.